VXRT:OTCMKTS
Vaxart Inc
$०.४३
arrow_downward
-०.८६%(-०.००३८) १ दि
७ ऑक्टो, १:४८:४० PM [GMT]-४ · USD
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_autoVXRT साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
$०.४३
उच्च
$०.४४
कमी
$०.४०
मार्केट कॅप
१०.४१ कोटी
सरासरी उलाढाल
२.५९ लाख
उलाढाल
२.७१ लाख
P/E रेशो
२.६५
५२ आठवड्यांतील उच्चांक
$०.८४
५२ आठवड्यांतील नीचांक
$०.३०
EPS
$०.१६
बीटा
१.०५
थकित शेअर
२४.२८ कोटी
कर्मचाऱ्यांची संख्या
६५
उघडा
$०.४३
उच्च
$०.४४
कमी
$०.४०
मार्केट कॅप
१०.४१ कोटी
सरासरी उलाढाल
२.५९ लाख
उलाढाल
२.७१ लाख
P/E रेशो
२.६५
५२ आठवड्यांतील उच्चांक
$०.८४
५२ आठवड्यांतील नीचांक
$०.३०
EPS
$०.१६
बीटा
१.०५
थकित शेअर
२४.२८ कोटी
कर्मचाऱ्यांची संख्या
६५
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
Reuters
·
४४ मिनिटांपूर्वी
FireFly Robotics files for Nasdaq direct listing
Yahoo Finance
·
१ तासापूर्वी
These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks
Simply Wall Street
·
१७ मिनिटांपूर्वी
Zscaler (ZS) CEO Challenges AI Risk Standards Publicly
Quartz
·
४ तासांपूर्वी
Dow drops 451 points as Treasury yields hit 24-year highs
प्रोफाइल
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in 2004, the company later changed its name to Vaxart, Inc. in July 2007, after reincorporating in Delaware. A significant development in the company's history was the reverse merger with Aviragen Therapeutics, Inc. on February 13, 2018, which led to Vaxart becoming a wholly owned subsidiary of Aviragen. Post-merger, the company continued as Vaxart, Inc.
Vaxart's development portfolio includes a range of oral vaccines targeting infectious diseases such as norovirus, COVID-19, and seasonal influenza, as well as therapeutic vaccines like those targeting HPV. Wikipedia
Vaxart Inc बद्दल
CEOस्टीवेन लो
कर्मचारी६५
स्थापनामार्च २००४
मुख्यालयेSouth San Francisco, कॅलिफोर्निया, संयुक्त राष्ट्र
क्षेत्र-
वेबसाइटvaxart.com